We have been granted an import licence by the ODC and will shortly be importing medicinal cannabis oils, capsules and dried flower, administered via a vapouriser, from our Canadian partner, MedReleaf Corp. We will provide products with a range of THC and CBD content, including a balanced formula.

    We expect to be able to supply these products to Australian pharmacies in 2018.

    Our aim in the near-term future is to establish an optimised indoor growing system, and manufacture Australian-produced GMP-certified medicinal cannabis oils and capsules using supercritical CO2 extraction techniques.

    Our Australian manufacturing systems will emulate MedReleaf Corp.’s systems in Canada, ensuring an uninterrupted supply of identical product as local production is introduced.